Form 4: Procter & Gamble Executive Moses Victor Javier Aguilar Reports Stock Transactions

Moses Victor Javier Aguilar, a Chief Research, Development & Innovation Officer at Procter & Gamble, reported the acquisition and disposal of company stock and derivative securities.

Summary

• On May 16, 2024, Moses Victor Javier Aguilar exercised stock options to acquire 9,149 shares of Procter & Gamble common stock at a price of $85.13.
• Aguilar then sold 9,149 shares of common stock at a weighted average price of $167.7177, with prices ranging from $167.69 to $167.755.
• Following these transactions, Aguilar directly owns 12,928.593 shares of common stock.
• Aguilar also indirectly owns 5,668.6434 shares through a retirement plan trustee and 428.6033 shares through an international stock ownership plan (Mexico) trustee.
• Additionally, Aguilar was awarded 8.1203 restricted stock units (RSUs) on February 15, 2024, which will be settled in common stock upon retirement.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive. The exercise of options and sale of shares could be interpreted as a positive sign (taking profit) or a neutral event (portfolio diversification).

Positives

• The exercise of stock options and subsequent sale suggests confidence in the company's prospects, as the executive capitalized on the difference between the exercise price ($85.13) and the market price (approximately $167.72).

Future Outlook

The document does not contain explicit forward-looking statements, but the executive's continued holdings of P&G stock and RSUs suggest a long-term commitment to the company.

Industry Context

Insider transactions are closely watched as indicators of management's sentiment about the company's future prospects. This Form 4 filing provides transparency into the trading activities of a key executive at Procter & Gamble.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are common in large, publicly traded companies like Procter & Gamble.
• The structure of these packages is often benchmarked against peer companies in the consumer goods industry, such as Unilever, Nestle, and Johnson & Johnson.
• The vesting schedules and performance metrics associated with these equity grants are designed to align executive incentives with shareholder value creation.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent a small fraction of the company's outstanding shares.
• However, transparency in insider trading activity is important for maintaining investor confidence.

Key Dates